StreetInsider

• Log in to your account:

  
  Log in
• Signup
• Home
• EPS Insider
• Event Calendar
• Conferences
• Classic Site

Upgrade to SI Premium - Free Trial

Organon (OGN)

FDA accepts review of application to extend Miudella IUD use to 6 years September 14, 2026 7:30 AM - StreetInsider Organon Announces US FDA Has Accepted for Review a Supplemental New Drug Application for MIUDELLA®, a Hormone-Free Intrauterine Device September 14, 2026 7:30 AM - BizWire Orogen Royalties acquires undrilled Nevada gold project September 10, 2026 7:31 AM - StreetInsider Orogen Royalties Acquires the Serpent Gold Project in Nevada September 10, 2026 7:31 AM - StreetInsider Orogen Royalties acquires two Utah gold projects with Triple Flag September 2, 2026 8:01 AM - StreetInsider Orogen Royalties Acquires Two Gold Projects in Southwest Utah September 2, 2026 8:01 AM - StreetInsider National Can-RISE Study to Help Close Critical Gaps in Menopause Research August 27, 2026 9:00 AM - Globe NewsWire Form 4 Organon & Co. For: Aug 11 Filed by: Arjona Ferreira Juan Camilo August 12, 2026 1:02 PM - SEC Filing Organon opens REMS enrollment for copper IUD ahead of late 2026 launch August 11, 2026 7:31 AM - StreetInsider Organon Opens REMS Program for MIUDELLA® Ahead of Anticipated Commercial Availability August 11, 2026 7:30 AM - BizWire Form 4 Organon & Co. For: Aug 05 Filed by: Drinane Juliana Papa August 5, 2026 4:05 PM - SEC Filing Organon (OGN) Declares $0.02 Quarterly Dividend; 0.6% Yield July 31, 2026 8:30 AM - StreetInsider Organon Announces Quarterly Dividend July 31, 2026 8:30 AM - BizWire Organon presents tapinarof cream data across age groups at SPD meeting July 24, 2026 8:00 AM - StreetInsider New Analysis of Phase 3 Pooled Data for Organon’s VTAMA® (tapinarof) cream, 1%, Demonstrates Early, Consistent Improvements in Atopic Dermatitis Patients Across Pediatric Age Groups and in Adults¹ July 24, 2026 8:00 AM - BizWire Altius Provides 2nd Quarter 2026 Project Generation Update July 17, 2026 7:45 AM - BizWire Organon to Report Second Quarter 2026 Results in Its Regularly Scheduled Form 10-Q Filing July 16, 2026 7:30 AM - BizWire Organon to present tapinarof cream data at pediatric dermatology meeting July 7, 2026 8:01 AM - StreetInsider Organon to Present New Analysis on VTAMA® (tapinarof) cream, 1%, at the 2026 Society for Pediatric Dermatology Annual Meeting July 7, 2026 8:00 AM - BizWire Organon launches two denosumab biosimilars in Canada June 23, 2026 5:38 AM - StreetInsider Organon Canada and Henlius Expand Access to Denosumab Treatments With Launch of BILDYOS® (denosumab injection) and TUZEMTY® (denosumab injection), Biosimilars to PROLIA and XGEVA June 23, 2026 5:30 AM - BizWire Organon closes license deal for copper IUD Miudella with Sebela June 22, 2026 7:30 AM - StreetInsider Organon Completes Agreement to License MIUDELLA®, Sebela Pharmaceuticals’ Hormone-Free Intrauterine Device June 22, 2026 7:30 AM - BizWire Organon and Samsung Bioepis add ustekinumab biosimilar to Canada deal June 18, 2026 6:01 AM - StreetInsider Organon and Samsung Bioepis Expand Agreement to Commercialize PYZCHIVA® (ustekinumab), a Biosimilar Referencing STELARA® (ustekinumab) in Canada June 18, 2026 6:00 AM - BizWire Full Article List